Suppr超能文献

相似文献

1
Structural Characterization of the Aurora Kinase B "DFG-flip" Using Metadynamics.
AAPS J. 2019 Dec 18;22(1):14. doi: 10.1208/s12248-019-0399-6.
2
Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states.
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11894-E11903. doi: 10.1073/pnas.1811158115. Epub 2018 Dec 5.
3
The Conformational Transition Pathways and Hidden Intermediates in DFG-Flip Process of c-Met Kinase Revealed by Metadynamics Simulations.
J Chem Inf Model. 2022 Aug 8;62(15):3651-3663. doi: 10.1021/acs.jcim.2c00770. Epub 2022 Jul 18.
4
A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A.
ACS Chem Biol. 2012 Apr 20;7(4):698-706. doi: 10.1021/cb200508b. Epub 2012 Jan 27.
5
Insights into MAPK p38alpha DFG flip mechanism by accelerated molecular dynamics.
Bioorg Med Chem. 2010 Sep 15;18(18):6805-12. doi: 10.1016/j.bmc.2010.07.047. Epub 2010 Jul 29.
8
Modeling conformational flexibility of kinases in inactive states.
Proteins. 2019 Nov;87(11):943-951. doi: 10.1002/prot.25756. Epub 2019 Jun 17.
9
Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib.
Phys Chem Chem Phys. 2016 Apr 21;18(15):10367-74. doi: 10.1039/c5cp07001e. Epub 2016 Mar 31.

引用本文的文献

2
Targeting RAF dimers in RAS mutant tumors: From biology to clinic.
Acta Pharm Sin B. 2024 May;14(5):1895-1923. doi: 10.1016/j.apsb.2024.02.018. Epub 2024 Feb 28.
6
Pyrrolo[2,3-d]pyrimidine derivatives as inhibitors of RET: Design, synthesis and biological evaluation.
Eur J Med Chem. 2020 Nov 15;206:112691. doi: 10.1016/j.ejmech.2020.112691. Epub 2020 Aug 6.

本文引用的文献

1
Predicting the Conformational Variability of Abl Tyrosine Kinase using Molecular Dynamics Simulations and Markov State Models.
J Chem Theory Comput. 2018 May 8;14(5):2721-2732. doi: 10.1021/acs.jctc.7b01170. Epub 2018 Apr 3.
3
Aurora kinases: novel therapy targets in cancers.
Oncotarget. 2017 Apr 4;8(14):23937-23954. doi: 10.18632/oncotarget.14893.
4
Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.
J Chem Inf Model. 2017 Feb 27;57(2):159-169. doi: 10.1021/acs.jcim.6b00679. Epub 2017 Jan 12.
6
Pharmacological Profile of BI 847325, an Orally Bioavailable, ATP-Competitive Inhibitor of MEK and Aurora Kinases.
Mol Cancer Ther. 2016 Oct;15(10):2388-2398. doi: 10.1158/1535-7163.MCT-16-0066. Epub 2016 Aug 5.
7
Molecular Dynamics Analysis of Binding of Kinase Inhibitors to WT EGFR and the T790M Mutant.
J Chem Theory Comput. 2016 Apr 12;12(4):2066-78. doi: 10.1021/acs.jctc.5b01221. Epub 2016 Apr 4.
8
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes.
Pharmacol Res. 2016 Jan;103:26-48. doi: 10.1016/j.phrs.2015.10.021. Epub 2015 Oct 31.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验